Silexion Therapeutics Corp - Ordinary Shares, par value $0.0135 per share (SLXN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2025

Type / Class
Equity / Ordinary Shares, par value $0.0135 per share
Symbol
SLXN on Nasdaq
Shares outstanding
3,127,635
Price per share
$1.73
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,085
Total reported value
$17,289
% of total 13F portfolios
0%
Share change
-31,329
Value change
-$54,719
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Silexion Therapeutics Corp - Ordinary Shares, par value $0.0135 per share (SLXN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Moringa Sponsor, LP 15% $3,321,886 458,824 Moringa Partners Ltd 15 Sep 2025
INTRACOASTAL CAPITAL, LLC 10% 244,771 Mitchell P. Kopin 11 Sep 2025
Orca Capital AG 4.9% 109,432 Orca Capital AG 11 Sep 2025

As of 30 Sep 2025, 4 institutional investors reported holding 5,085 shares of Silexion Therapeutics Corp - Ordinary Shares, par value $0.0135 per share (SLXN). This represents 0.16% of the company’s total 3,127,635 outstanding shares.

Institutional Holders of Silexion Therapeutics Corp - Ordinary Shares, par value $0.0135 per share (SLXN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 5,085 $17,289 -$54,719 $3.40 4
2025 Q2 36,414 $29,495 +$29,495 $0.81 2